Search - tctmd.com

Displaying 41 - 60 of 665

Sort: Relevancy | Date

Presentation TCT 2017

Frequency of MR and Clinical Management Issues in TAVR Patients

Presenter: Marco Barbanti

November 01, 2017

Presentation TCT 2017

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

Presenter: Ariel Finkelstein, Ran Kornowski, Yusuke Watanabe

November 01, 2017

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Presenter: Didier Tchetche

November 01, 2017

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Presenter: Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Steven R. Bailey, Patrick W. Serruys, Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

TAVR in Symptomatic High-risk Aortic Regurgitation: Case Selection, Devices and Preliminary Clinical Outcomes

Presenter: Ariel Finkelstein, Ran Kornowski, Hendrik Treede

November 01, 2017

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Presentation TCT 2017

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD

November 01, 2017

Presentation TCT 2017

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer

November 01, 2017

Presentation TCT 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presenter: Gilles Dreyfus, Sanjay Kaul, Raj Makkar

November 01, 2017

Presentation TCT 2017

TAVR: Current Devices and Indications

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Vinod H. Thourani

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Advertisement

Frequency of MR and Clinical Management Issues in TAVR Patients

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

TAVR in Symptomatic High-risk Aortic Regurgitation: Case Selection, Devices and Preliminary Clinical Outcomes

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

TAVR: Current Devices and Indications

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content